EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Assessing the risk of drug-induced corrected QT interval prolongation in primary care

Divya Garg iD, Vishal S Bhella, Trudy Huyghebaert

Family Practice · 11.06.2026 · 43 (4)

DOI: 10.1093/fampra/cmag048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Family Practice, online erschienen am 04.07.2026. Verfasst von Divya Garg und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine, University of Calgary, Calgary, Alberta, Canada T2N4N1. Hauptthemen laut MEDLINE: Long QT Syndrome, Primary Health Care, Psychotropic Drugs. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tisdale risk score has been validated for predicting drug-induced QTc prolongation (QTP) in cardiac care. This study aims to determine whether it can guide prescribing and monitoring of QTc-prolonging medications in primary care.

Methods

A retrospective chart audit using Tisdale Risk Score was conducted. Data from 486 primary care patients from two Family Medicine Clinics, prescribed medications with known or possible risk of Torsades de Pointes (TdP) were reviewed. Eighty-five patients with pre- and post-pharmacotherapy ECGs comprised the cases. A control group of 184 patients not on QTc-prolonging medications was assessed. Patients were categorized as low, moderate, or high risk for QTP.

Results

Psychotropics were the most frequently prescribed QTc-prolonging medications. Baseline QTc did not differ significantly between cases (428 ms) and controls (426 ms). Among cases, most were stratified as low risk (69.4%), with fewer in moderate (25.9%) and high-risk (4.7%) categories. Comparatively, 99.5% of control patients were at low risk. QTc prolongation occurred in 5/85 (5.9%) post-pharmacotherapy, with none in the high-risk category. Odds ratio for QTP in moderate-risk patients versus low-risk was 0.71 (95% CI: 0.07–6.98).

Conclusions

Most primary care patients were at low risk for drug-induced QTc prolongation. QTP events were low with none in the high-risk category, which limited evaluation of association between risk categories and QTc prolongation. The study highlights commonly prescribed QTc-prolonging medications in family medicine and their variable QTc effects, emphasizing the need for an outpatient-tailored risk assessment tool.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Long QT SyndromePrimary Health CarePsychotropic DrugsHumansRetrospective StudiesFemaleElectrocardiographyRisk AssessmentMaleMiddle AgedAgedTorsades de PointesAdultRisk Factors

Stichwörter der Autor:innen

QTc-prolonging medicationsprescribingprimary carepsychotropics

Substanzen

Psychotropic Drugs

Autor:innen und Institutionen

  • Department of Family Medicine, University of Calgary, Calgary, Alberta, Canada T2N4N1.
  • School of Health and Wellness, Bow Valley College, Calgary, Alberta, Canada T2G4V1.

ORCID-Profile: Divya Garg

Zitieren

APA

Garg, D., Bhella, V. S., & Huyghebaert, T. (2026). Assessing the risk of drug-induced corrected QT interval prolongation in primary care. Family Practice, 43(4). https://doi.org/10.1093/fampra/cmag048

Vancouver

Garg D, Bhella VS, Huyghebaert T. Assessing the risk of drug-induced corrected QT interval prolongation in primary care. Family Practice. 2026;43(4). doi:10.1093/fampra/cmag048

BibTeX
@article{Garg2026,
  author = {Garg, Divya and Bhella, Vishal S and Huyghebaert, Trudy},
  title = {Assessing the risk of drug-induced corrected QT interval prolongation in primary care},
  journal = {Family Practice},
  year = {2026},
  volume = {43},
  number = {4},
  doi = {10.1093/fampra/cmag048}
}
Kostenlos starten →